Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
International Journal of Obesity (2005)|October 10, 2017
Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistanceW A Banks, S A Farr, T S Salameh, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2017
Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesityDongfen Yuan, Xiang Yi, Yuling Zhao, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2019
A simplified blood culture sampling protocol for reducing contamination and costs: a randomized controlled trialA Lalezari, M J Cohen, O Svinik, et al.Journal of Neuroinflammation|November 27, 2015
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unitWilliam A Banks, Alicia M Gray, Michelle A Erickson, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2017
Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axisMichelle A Erickson, Joseph Jude, Hengjiang Zhao, et al.International Journal of Molecular Sciences|March 25, 2017
Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in RodentsDora Werling, William A Banks, Therese S Salameh, et al.Investigative Ophthalmology & Visual Science|December 10, 2016
Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in RodentsDora Werling, Dora Reglodi, William A Banks, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosisChristina N Fournier, David Schoenfeld, James D Berry, et al.Scientific Reports|June 12, 2023
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight lossKylie S Chichura, Clinton T Elfers, Therese S Salameh, et al.Frontiers in Immunology|May 7, 2024
Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer modelKhan Mohammad Imran, Rebecca M Brock, Natalie Beitel-White, et al.Pageof 7